These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
804 related articles for article (PubMed ID: 16474180)
1. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells. Mi Z; Guo H; Wai PY; Gao C; Kuo PC Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180 [TBL] [Abstract][Full Text] [Related]
2. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells. Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636 [TBL] [Abstract][Full Text] [Related]
3. Critical involvement of ILK in TGFbeta1-stimulated invasion/migration of human ovarian cancer cells is associated with urokinase plasminogen activator system. Lin SW; Ke FC; Hsiao PW; Lee PP; Lee MT; Hwang JJ Exp Cell Res; 2007 Feb; 313(3):602-13. PubMed ID: 17187779 [TBL] [Abstract][Full Text] [Related]
4. The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Troussard AA; Costello P; Yoganathan TN; Kumagai S; Roskelley CD; Dedhar S Oncogene; 2000 Nov; 19(48):5444-52. PubMed ID: 11114721 [TBL] [Abstract][Full Text] [Related]
5. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression. Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053 [TBL] [Abstract][Full Text] [Related]
6. Osteopontin increases migration and MMP-9 up-regulation via alphavbeta3 integrin, FAK, ERK, and NF-kappaB-dependent pathway in human chondrosarcoma cells. Chen YJ; Wei YY; Chen HT; Fong YC; Hsu CJ; Tsai CH; Hsu HC; Liu SH; Tang CH J Cell Physiol; 2009 Oct; 221(1):98-108. PubMed ID: 19475568 [TBL] [Abstract][Full Text] [Related]
7. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model. Mitra SK; Lim ST; Chi A; Schlaepfer DD Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501 [TBL] [Abstract][Full Text] [Related]
8. Interaction between cancer cells and stromal fibroblasts is required for activation of the uPAR-uPA-MMP-2 cascade in pancreatic cancer metastasis. He Y; Liu XD; Chen ZY; Zhu J; Xiong Y; Li K; Dong JH; Li X Clin Cancer Res; 2007 Jun; 13(11):3115-24. PubMed ID: 17545513 [TBL] [Abstract][Full Text] [Related]
9. Osteopontin silencing by small interfering RNA suppresses in vitro and in vivo CT26 murine colon adenocarcinoma metastasis. Wai PY; Mi Z; Guo H; Sarraf-Yazdi S; Gao C; Wei J; Marroquin CE; Clary B; Kuo PC Carcinogenesis; 2005 Apr; 26(4):741-51. PubMed ID: 15661802 [TBL] [Abstract][Full Text] [Related]
10. Alpha-V-dependent outside-in signaling is required for the regulation of CD44 surface expression, MMP-2 secretion, and cell migration by osteopontin in human melanoma cells. Samanna V; Wei H; Ego-Osuala D; Chellaiah MA Exp Cell Res; 2006 Jul; 312(12):2214-30. PubMed ID: 16631740 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA. Chen RX; Xia YH; Xue TC; Zhang H; Ye SL Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression. Sawai H; Okada Y; Funahashi H; Matsuo Y; Takahashi H; Takeyama H; Manabe T BMC Cell Biol; 2006 Feb; 7():8. PubMed ID: 16504015 [TBL] [Abstract][Full Text] [Related]
13. Integrin alphavbeta3 upregulates integrin-linked kinase expression in human ovarian cancer cells via enhancement of ILK gene transcription. Lössner D; Abou-Ajram C; Benge A; Aumercier M; Schmitt M; Reuning U J Cell Physiol; 2009 Aug; 220(2):367-75. PubMed ID: 19334037 [TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-2: mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion. Philip S; Bulbule A; Kundu GC Glycoconj J; 2004; 21(8-9):429-41. PubMed ID: 15750784 [TBL] [Abstract][Full Text] [Related]
15. A transcriptional repressor of osteopontin expression in the 4T1 murine breast cancer cell line. Gao C; Mi Z; Guo H; Wei J; Wai PY; Kuo PC Biochem Biophys Res Commun; 2004 Sep; 321(4):1010-6. PubMed ID: 15358129 [TBL] [Abstract][Full Text] [Related]
16. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression. Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287 [TBL] [Abstract][Full Text] [Related]
17. A short-hairpin RNA targeting osteopontin downregulates MMP-2 and MMP-9 expressions in prostate cancer PC-3 cells. Liu H; Chen A; Guo F; Yuan L Cancer Lett; 2010 Sep; 295(1):27-37. PubMed ID: 20207476 [TBL] [Abstract][Full Text] [Related]